Cargando…

Integration of Tobacco Treatment Services into Cancer Care at Stanford

As part of a National Cancer Institute Moonshot P30 Supplement, the Stanford Cancer Center piloted and integrated tobacco treatment into cancer care. This quality improvement (QI) project reports on the process from initial pilot to adoption within 14 clinics. The Head and Neck Oncology Clinic was e...

Descripción completa

Detalles Bibliográficos
Autores principales: Gali, Kathleen, Pike, Brittany, Kendra, Matthew S., Tran, Cindy, Fielding-Singh, Priya, Jimenez, Kayla, Mirkin, Rachelle, Prochaska, Judith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143650/
https://www.ncbi.nlm.nih.gov/pubmed/32235713
http://dx.doi.org/10.3390/ijerph17062101
_version_ 1783519662554742784
author Gali, Kathleen
Pike, Brittany
Kendra, Matthew S.
Tran, Cindy
Fielding-Singh, Priya
Jimenez, Kayla
Mirkin, Rachelle
Prochaska, Judith J.
author_facet Gali, Kathleen
Pike, Brittany
Kendra, Matthew S.
Tran, Cindy
Fielding-Singh, Priya
Jimenez, Kayla
Mirkin, Rachelle
Prochaska, Judith J.
author_sort Gali, Kathleen
collection PubMed
description As part of a National Cancer Institute Moonshot P30 Supplement, the Stanford Cancer Center piloted and integrated tobacco treatment into cancer care. This quality improvement (QI) project reports on the process from initial pilot to adoption within 14 clinics. The Head and Neck Oncology Clinic was engaged first in January 2019 as a pilot site given staff receptivity, elevated smoking prevalence, and a high tobacco screening rate (95%) yet low levels of tobacco cessation treatment referrals (<10%) and patient engagement (<1% of smokers treated). To improve referrals and engagement, system changes included an automated “opt-out” referral process and provision of tobacco cessation treatment as a covered benefit with flexible delivery options that included phone and telemedicine. Screening rates increased to 99%, referrals to 100%, 74% of patients were reached by counselors, and 33% of those reached engaged in treatment. Patient-reported abstinence from all tobacco products at 6-month follow-up is 20%. In July 2019, two additional oncology clinics were added. In December 2019, less than one year from initiating the QI pilot, with demonstrated feasibility, acceptability, and efficacy, the tobacco treatment services were integrated into 14 clinics at Stanford Cancer Center.
format Online
Article
Text
id pubmed-7143650
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71436502020-04-14 Integration of Tobacco Treatment Services into Cancer Care at Stanford Gali, Kathleen Pike, Brittany Kendra, Matthew S. Tran, Cindy Fielding-Singh, Priya Jimenez, Kayla Mirkin, Rachelle Prochaska, Judith J. Int J Environ Res Public Health Article As part of a National Cancer Institute Moonshot P30 Supplement, the Stanford Cancer Center piloted and integrated tobacco treatment into cancer care. This quality improvement (QI) project reports on the process from initial pilot to adoption within 14 clinics. The Head and Neck Oncology Clinic was engaged first in January 2019 as a pilot site given staff receptivity, elevated smoking prevalence, and a high tobacco screening rate (95%) yet low levels of tobacco cessation treatment referrals (<10%) and patient engagement (<1% of smokers treated). To improve referrals and engagement, system changes included an automated “opt-out” referral process and provision of tobacco cessation treatment as a covered benefit with flexible delivery options that included phone and telemedicine. Screening rates increased to 99%, referrals to 100%, 74% of patients were reached by counselors, and 33% of those reached engaged in treatment. Patient-reported abstinence from all tobacco products at 6-month follow-up is 20%. In July 2019, two additional oncology clinics were added. In December 2019, less than one year from initiating the QI pilot, with demonstrated feasibility, acceptability, and efficacy, the tobacco treatment services were integrated into 14 clinics at Stanford Cancer Center. MDPI 2020-03-22 2020-03 /pmc/articles/PMC7143650/ /pubmed/32235713 http://dx.doi.org/10.3390/ijerph17062101 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gali, Kathleen
Pike, Brittany
Kendra, Matthew S.
Tran, Cindy
Fielding-Singh, Priya
Jimenez, Kayla
Mirkin, Rachelle
Prochaska, Judith J.
Integration of Tobacco Treatment Services into Cancer Care at Stanford
title Integration of Tobacco Treatment Services into Cancer Care at Stanford
title_full Integration of Tobacco Treatment Services into Cancer Care at Stanford
title_fullStr Integration of Tobacco Treatment Services into Cancer Care at Stanford
title_full_unstemmed Integration of Tobacco Treatment Services into Cancer Care at Stanford
title_short Integration of Tobacco Treatment Services into Cancer Care at Stanford
title_sort integration of tobacco treatment services into cancer care at stanford
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143650/
https://www.ncbi.nlm.nih.gov/pubmed/32235713
http://dx.doi.org/10.3390/ijerph17062101
work_keys_str_mv AT galikathleen integrationoftobaccotreatmentservicesintocancercareatstanford
AT pikebrittany integrationoftobaccotreatmentservicesintocancercareatstanford
AT kendramatthews integrationoftobaccotreatmentservicesintocancercareatstanford
AT trancindy integrationoftobaccotreatmentservicesintocancercareatstanford
AT fieldingsinghpriya integrationoftobaccotreatmentservicesintocancercareatstanford
AT jimenezkayla integrationoftobaccotreatmentservicesintocancercareatstanford
AT mirkinrachelle integrationoftobaccotreatmentservicesintocancercareatstanford
AT prochaskajudithj integrationoftobaccotreatmentservicesintocancercareatstanford